Andean Pacific Workshop on HIV & Hepatitis

  Session 1: Challenges for HIV care in Latin America
 
HIV in Latin America: 35 years later
Dr. Wolff
Universidad de Chile, Santiago, Chile
 
WHO Target 90-90-90 : Achievable for Latin America
Dr. Afani
Universidad de Chile, Santiago, Chile
 
Difficult to reach populations in Latin America
Dr. Celi
Asociación Panamericana de Infectología, Quito, Equador
  Session 2: Prevention to transmission
 
New approaches for preventing transmission
Dr. Boucher
Erasmus Medical Center, Rotterdam, The Netherlands
 
State-of-the-Art lecture on PrEP
Dr. Schechter
Federal University of Rio de Janeiro, Rio de Janeiro, Brasil
  Session 3: Clinical strategies
 

Clinical Implications of Low level viremia / failure and resistance
Dr. Ceccherini
University of Rome Tor Vergata, Rome, Italy

  Abstract presentations
 Proviral DNA as a Target for HIV-1 Resistance Analysis
Dr. Lara
SidaChile, Santiago, Chile
 Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017
Dr. Palma
SidaChile, Santiago, Chile
 Transmitted HIV Resistance in ART-Naïve Patients, Colombia (not available)
Dr. Galindo-Orrego
Taller Latinoamericano, Bogotá, Colombia
 Risk factors for virologic failure in a cohort of patients with HIV in Colombia (coming soon)
Dr. Del Carmen Figueredo Pena
University Hospital San Ignacio, Bogotá, Colombia
  Session 4: Diagnostic tools
 
Early Diagnosis & Testing
Dr. Cabrera
Universidad de la República, Montevideo, Uruguay
  Abstract presentations
 Risk profiles for HIV transmission and HIV status in MSM versus heterosexual men populations in the South West of Colombia.
Dr. Mueses-Marín
Corporación De Lucha Contra El Sida, Valle del Cauca, Colombia
 Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina.
Dr. Barletta
Hospital General De Agudos Juan A. Fernández, Argentina
 High rates of retention on ART and virological suppression in a large cohort study from The Chilean AIDS Group
Dr. Beltrán
Chilean AIDS Cohort (ChiAC), Santiago, Chile
  Session 5: Viral hepatitis in Latin America
 
Local situation in LA (epidemiology / treatment options) (coming soon)
Dr. Contreras
Clínica Alemana - Universidad del Desarrollo Chile, Santiago, Chile
 
Implementation of DAAs in clinical management
Dr. Nelson
Chelsea and Westminster Hospital, London, UK
 

Strategies for Hepatitis C Elimination
Dr. Ceccherini
University of Rome Tor Vergata, Rome, Italy

  Session 6: Special Populations
 
HIV-Hepatitis co-infected patient
Dr. Cahn
Fundación Huésped, Buenos Aires, Argentina
 
HIV in Women - PTMCT - pregnancy
Dr. Cassetti
Fundación Helios Salud, Buenos Aires, Argentina
 
The aging HIV infected patient - neurological issues - poly pharmacy
Dr. Martinez Buitrago
Universidad del Valle, Cali, Colombia
  Session 7: ARV Therapy: present and future
 
Do we really need new drugs? (not available)
Dr. Nelson
Chelsea and Westminster Hospital, London, UK
 
Present and future of ART in Latin America
Dr. Beltrán
Chilean AIDS Cohort (ChiAC), Santiago, Chile
 
HIV cure and eradication
Dr. Diaz
NIFESP Laboratorio de Retrovirologia, São Paulo, Brasil